Anticoagulant sulfated polysaccharides: Part I. Synthesis and structure-activity relationships of new pullulan sulfates

被引:207
作者
Alban, S [1 ]
Schauerte, A [1 ]
Franz, G [1 ]
机构
[1] Univ Regensburg, Inst Pharm, D-93040 Regensburg, Germany
关键词
sulfated polysaccharides; pullulan sulfates; partial synthesis; anticoagulant activity; structure-activity relationships;
D O I
10.1016/S0144-8617(01)00178-3
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
In order to develop new anticoagulants as potential heparin alternatives, two pullulans with different molecular weight (MW) were used as starting polymers for the partial synthesis of a structurally new class of sulfated polysaccharides. Sulfation of these linear alpha- 1,4-/1,6-glucans was carried out by a method with a SO3-pyridine complex in DMF, which had been optimized for the modification of beta -1,3-glucans. Modifications of this methods resulted in pullulan sulfates with degrees of sulfation (DS) ranging from 0.17 to 1.99 and MW between 15 and 250 kDa. More than 50% of the sulfate groups were bound to the secondary C atoms in positions 2, 3 and 4 of the glucose monomers. The anticoagulant activity of the obtained pullulan sulfates was determined in the coagulation assays prothrombin time (PT), activated partial thromboplastin time (APTT), Heptest((R)) and thrombin time (TT). They represent potent anticoagulants reaching the efficacy of heparin. Their activity not only improves with increasing DS and MW, but also: with increasing part of sulfate groups in positions 2, 3 and 4. In addition, their action profile changes in dependence on their individual structure as reflected by the ratio of the TT- to the APTT-activity. The pullulan sulfates specifically interfere with different stages of the coagulation cascade, and these interactions have different requirements on the chemical structure. (C) 2002 Elsevier Science Ltd. All fights reserved.
引用
收藏
页码:267 / 276
页数:10
相关论文
共 47 条
[1]  
ALBAN S, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1005
[2]   ANTICOAGULANT AND ANTITHROMBOTIC ACTIONS OF A SEMISYNTHETIC BETA-1,3-GLUCAN SULFATE [J].
ALBAN, S ;
JESKE, W ;
WELZEL, D ;
FRANZ, G ;
FAREED, J .
THROMBOSIS RESEARCH, 1995, 78 (03) :201-210
[3]   GAS-LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY ANALYSIS OF ANTICOAGULANT ACTIVE CURDLAN SULFATES [J].
ALBAN, S ;
FRANZ, G .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1994, 20 (02) :152-158
[4]   ANTICOAGULANT ACTIVITIES OF BETA-1,3-GLUCANSULFATES IN DEPENDENCE ON THEIR MOLECULAR-WEIGHT [J].
ALBAN, S ;
FRANC, G .
PURE AND APPLIED CHEMISTRY, 1994, 66 (10-11) :2403-2406
[5]  
ALBAN S, 1993, THESIS U REGENSBURG
[6]  
ALBAN S, 1997, CARBOHYDRATES DRUG D, P209
[7]  
ARFORS KE, 1993, J LAB CLIN MED, V121, P201
[8]   INVITRO EFFECT ON HEPTEST OF LOW-MOLECULAR-WEIGHT HEPARIN FRACTIONS AND PREPARATIONS WITH VARIOUS ANTI-IIA AND ANTI-XA ACTIVITIES [J].
BARA, L ;
MARDIGUIAN, J ;
SAMAMA, M .
THROMBOSIS RESEARCH, 1990, 57 (04) :585-592
[9]   Novel regio- and stereoselective O-6-desulfation of the glucosamine moiety of heparin with N-methylpyrrolidinone-water or N,N-dimethylformamide-water mixtures [J].
Baumann, H ;
Scheen, M ;
Huppertz, B ;
Keller, R .
CARBOHYDRATE RESEARCH, 1998, 308 (3-4) :381-388
[10]  
Boisson-Vidal C., 1995, Drugs of the Future, V20, P1237